Literature DB >> 498095

Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.

M Modolell, R Andreesen, W Pahlke, U Brugger, P G Munder.   

Abstract

Alkyl-lysophospholipids inhibit the growth of Meth A sarcoma cells in vitro. In contrast, murine bone marrow macrophages are not sensitive to the destructive effect of these substances. Since alkyl-lysophospholipids are antimetabolites in the synthesis of 3-sn-phosphatidylcholine, tumor cell destruction can be correlated with the disturbance of this metabolism. A decreased synthesis of 3-sn-phosphatidylcholine is accompanied by an increased degradation of cellular 3-sn-phosphatidylcholine in the presence of alkyl-lysophospholipids. As a consequence, endogeneously formed lysophospholipid accumulates, although the lysophospholipase is found to be stimulated. This accumulation of endogeneous lysophospholipids might be due to the fact that a high percentage of these compounds contain an alkyl bond which cannot be split by a lysophospholipase. On the other hand, the reacylation of the formed lysophospholipids is partially blocked as the lysophosphatidylcholine acyltransferase is inhibited by the added alkyllysophospholipids. An accumulation of potentially cytotoxic lysophospholipids in tumor cells might be an additional factor in the tumor cell destruction by alkyl-lysophospholipids.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498095

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Activation of macrophages by ether analogues of lysophospholipids.

Authors:  N Yamamoto; B Z Ngwenya; T W Sery; R A Pieringer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 3.  Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.

Authors:  Kerstin Danker; Werner Reutter; Geo Semini
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

4.  Ether lipids in oncology-welcoming address.

Authors:  O Westphal
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

5.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

6.  De novo fatty acid synthesis at the mitotic exit is required to complete cellular division.

Authors:  Natalia Scaglia; Svitlana Tyekucheva; Giorgia Zadra; Cornelia Photopoulos; Massimo Loda
Journal:  Cell Cycle       Date:  2014-01-13       Impact factor: 4.534

7.  Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells.

Authors:  M Shoji; R L Raynor; E A Fleer; H Eibl; W R Vogler; J F Kuo
Journal:  Lipids       Date:  1991-02       Impact factor: 1.880

8.  Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11.

Authors:  J Kára; N I Zimakova; E A Serebryakova; V Dĕdková; A E Zolotaryov
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  Response of acute myelomonocytic leukemia to alkyl-lysophospholipids. A case report.

Authors:  W E Berdel; U Fink; P A Maubach; B Permanetter; J Rastetter
Journal:  Blut       Date:  1982-03

10.  The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells.

Authors:  F Mollinedo; C Gajate; M Modolell
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.